UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1876
Praxis Precision Medicines
PRAX
$7.95B
| $43.9M | 0.01% |
131,046
+22,600
| +21% | +$7.15M |
2023 Q4
10 quarters
|
|
1877
PUT
State Street Technology Select Sector SPDR ETF
XLK
$117B
| $43.8M | 0.01% |
230,000
-29,600
| -11% | -$5.06M |
2016 Q2
40 quarters
|
|
1878
Renasant Corp
RNST
$3.66B
| $43.8M | 0.01% |
1,028,702
+607,441
| +144% | +$24.6M |
2014 Q4
46 quarters
|
|
1879
CALL
Life360
LIF
$3.92B
| $43.8M | 0.01% |
790,400
| – | – |
2025 Q2
4 quarters
|
|
1880
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.28B
| $43.7M | 0.01% |
225,676
+4,862
| +2% | +$859K |
2014 Q4
46 quarters
|
|
1881
CALL
Fastly Inc
FSLY
$3.35B
| $43.7M | 0.01% |
2,380,980
+5,000
| +0.2% | +$109K |
2023 Q1
13 quarters
|
|
1882
PUT
Blackrock
BLK
$189B
| $43.7M | 0.01% |
45,400
-27,100
| -37% | -$28M |
2017 Q3
35 quarters
|
|
1883
Paycom
PAYC
$12.1B
| $43.6M | 0.01% |
347,285
-158,902
| -31% | -$20.7M |
2014 Q4
46 quarters
|
|
1884
Baldwin Insurance Group
BWIN
$4.52B
| $43.6M | 0.01% |
1,641,349
+374,524
| +30% | +$8.1M |
2019 Q4
26 quarters
|
|
1885
BrightSpring Health Services
BTSG
$13.9B
| $43.5M | 0.01% |
623,476
+69,816
| +13% | +$3.88M |
2024 Q1
9 quarters
|
|
1886
Mobileye
MBLY
$4.54B
| $43.4M | 0.01% |
4,488,574
+741,502
| +20% | +$6.61M |
2022 Q4
14 quarters
|
|
1887
iShares Morningstar Value ETF
ILCV
$1.4B
| $43.4M | 0.01% |
429,086
-7,691
| -2% | -$764K |
2014 Q4
46 quarters
|
|
1888
Cogent Biosciences
COGT
$5.46B
| $43.4M | 0.01% |
1,122,245
+830,759
| +285% | +$29.1M |
2022 Q1
17 quarters
|
|
1889
Global X Defense Tech ETF
SHLD
$6.35B
| $43.4M | 0.01% |
727,323
-87,127
| -11% | -$5.8M |
2025 Q1
5 quarters
|
|
1890
Invesco BulletShares 2032 Corporate Bond ETF
BSCW
$1.56B
| $43.4M | 0.01% |
2,116,835
+83,183
| +4% | +$1.71M |
2023 Q1
13 quarters
|
|
1891
Zurn Elkay Water Solutions
ZWS
$7.45B
| $43.4M | 0.01% |
858,771
-157,442
| -15% | -$7.7M |
2014 Q4
46 quarters
|
|
1892
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.08B
| $43.3M | 0.01% |
440,630
-7,874
| -2% | -$711K |
2024 Q2
8 quarters
|
|
1893
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.2B
| $43.3M | 0.01% |
643,621
-137,358
| -18% | -$9.18M |
2014 Q4
46 quarters
|
|
1894
Mueller Industries
MLI
$12B
| $43.3M | 0.01% |
703,872
-1,257,166
| -64% | -$82.4M |
2014 Q4
46 quarters
|
|
1895
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.78B
| $43.2M | 0.01% |
270,962
-2,940
| -1% | -$426K |
2014 Q4
46 quarters
|
|
1896
CALL
Global X Uranium ETF
URA
$4.57B
| $43.2M | 0.01% |
989,000
+917,863
| +1,290% | +$46.5M |
2025 Q2
4 quarters
|
|
1897
NEOS Nasdaq 100 High Income ETF
QQQI
$14.8B
| $43.2M | 0.01% |
760,789
+271,478
| +55% | +$14.9M |
2024 Q2
8 quarters
|
|
1898
Ceco Environmental
CECO
$2.66B
| $43.1M | 0.01% |
475,224
+274,117
| +136% | +$21.7M |
2020 Q4
22 quarters
|
|
1899
Houlihan Lokey
HLI
$10.7B
| $43.1M | 0.01% |
321,436
-37,669
| -10% | -$5.56M |
2015 Q3
43 quarters
|
|
1900
Voya Financial
VOYA
$9.48B
| $43.1M | 0.01% |
475,925
+212,041
| +80% | +$17.3M |
2014 Q4
46 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.